PACB Stock Performance, Insider Transaction and News

PACB - Pacific Biosciences of Californ

Market Cap	3.13B	P/E	-	EPS this Y	-13.20%	Ern Qtrly Grth	-
Income	-400.38M	Forward P/E	-12.52	EPS next Y	49.60%	50D Avg Chg	-5.00%
Sales	188.87M	PEG	1.18	EPS past 5Y	-	200D Avg Chg	17.00%
Dividend	N/A	Price/Book	4.88	EPS next 5Y	-1.00%	52W High Chg	-14.00%
Recommedations	2.30	Quick Ratio	6.92	Shares Outstanding	272.53M	52W Low Chg	162.00%
Insider Own	1.87%	ROA	-11.24%	Shares Float	270.90M	Beta	2.03
Inst Own	85.60%	ROE	-70.57%	Shares Shorted/Prior	46.53M/59.96M	Price	12.52
Gross Margin	31.41%	Profit Margin	-211.99%	Avg. Volume	3,583,696	Target Price	2.83
Oper. Margin	-176.74%	Earnings Date	Oct 28	Volume	6,211,175	Change	-6.15%

Healthcare | Medical Devices | United States

About Pacific Biosciences of Californ

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of Californ News

11/19/24	Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now
11/12/24	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11/12/24	Pacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/09/24	Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
11/08/24	PacBio to Present at Upcoming Investor Conferences
11/08/24	PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y
11/08/24	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ...
11/07/24	Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11/07/24	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
11/07/24	Pacific Biosciences: Q3 Earnings Snapshot
11/07/24	PacBio Announces Third Quarter 2024 Financial Results
11/07/24	PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
11/06/24	PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
11/04/24	Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics
10/31/24	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
10/30/24	Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology
10/30/24	Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep
10/29/24	PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500
10/29/24	Pacific Biosciences of California, Inc. (NASDAQ:PACB) is a favorite amongst institutional investors who own 86%
10/22/24	PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

PACB Chatroom

Fatmofo Posted - 4 hours ago

$PACB I’m in - I bought yesterday Get used to seeing me post a lot on this channel

Helloa11 Posted - 12 hours ago

$PACB Added !

WallStreetBuyDip Posted - 13 hours ago

I make result summaries to see if the strategy worked out or not. This is the result from only buying when H% is low. This is the track record showing the results for Small + Mid cap stocks. All include timestamps + buy fills for everything. The result speaks for itself. Will trade $OCGN + $PACB when H% is low like I did for other small + mid cap stocks. How do you trade in the market?

2019Vtrader2025 Posted - 13 hours ago

$CERS this one’s dead in the water, ark number one holder not buying. She’s buying $PACB though. Two very different companies within the medical sector

2019Vtrader2025 Posted - 14 hours ago

$PACB I am excited more than ever knowing that yesterday support was mostly hedge funds and institutions, I was worried it was just a bull trap upward momentum to catch the retail yet again. It’s bull time!

De23 Posted - 14 hours ago

$PACB The last time the stock traded over its 50 and 200 dma it went from $2 to $50… that was 2020-2021, this stock has not been able up break resistance of its 200dma and continues to trace back down. It looks like it may finally have momentum as long as market conditions do not change. The 3 month chart shows we are in uptrend but that doesn’t mean much if we can’t break our 200dma. Lastly after finding out bad news about a friend, I’m reminded next week isn’t promised. Enjoy the time you have on earth; eternity for many of use will start tomorrow. And if you’re not going through something right now in the words of my pastor, “Just keep on living” because it will come. One Love

HampCo Posted - 14 hours ago

$PACB

2019Vtrader2025 Posted - 17 hours ago

$PACB added

2019Vtrader2025 Posted - 18 hours ago

$PACB consolidation here at the dollar $1.60 range before takeoff

kp2012 Posted - 18 hours ago

$PACB exceptionally weak open. should be trading back in the 2’s. maybe the 3’s. someone knows something.

2019Vtrader2025 Posted - 18 hours ago

$PACB

2019Vtrader2025 Posted - 19 hours ago

$PACB where’s my friend @MingLin

Giorgiooo Posted - 19 hours ago

$PACB ?

2019Vtrader2025 Posted - 1 day ago

$PACB ark purchase today

Carmichael77 Posted - 1 day ago

$PACB https://www.insidermonkey.com/blog/pacific-biosciences-of-california-inc-pacb-among-the-best-genomics-stocks-to-buy-right-now-1393963/

arielkhanMD Posted - 1 day ago

$PACB beautiful engulfing candle

2019Vtrader2025 Posted - 1 day ago

$PACB now the question is are we gonna start getting rejection at these levels, happened before. it was a strong resistance level when trading down here

2019Vtrader2025 Posted - 1 day ago

$PACB 3 million bid versus 800,000 asking, talk about buying power overcoming the stock

FaFan Posted - 1 day ago

$PACB is it possible that we are trending today?

spongebob_squaretrades Posted - 1 day ago

$PACB I know it's tempting fate, but had to pick up more shares @ 1.50 this morning. Too good to pass up the opportunity.

Craneton Posted - 1 day ago

$PACB $XBI Until this actually gets over $3 and holds for more than a day there’s nothing to be excited about.

2019Vtrader2025 Posted - 1 day ago

$PACB $XBI coming back to life today

2019Vtrader2025 Posted - 1 day ago

$PACB this is what I was looking for, now we might have a breakout and process and that’s the bottom the stock needed. Let’s go

2019Vtrader2025 Posted - 1 day ago

$PACB 50 day moving average inching closer to the 200 day now, we’re about $.50 away and squeezing

rubystocks Posted - 1 day ago

$PACB added shares at $1.52 this morning, ready for the rebound 🚀

Helloa11 Posted - 1 day ago

$PACB Cathie , please load up again. Really optimistic about the future. Things are going well.

PatrickBateman69 Posted - 1 day ago

$PACB Waiting for some lower levels before an entry, want to see them stabilize first, hopefully soon!

Ares77manoe Posted - 1 day ago

$PACB bears trying to lure you...

Ares77manoe Posted - 1 day ago

$PACB shopping day

hawksfan0420 Posted - 1 day ago

$PACB I used to trade this when it was over 10. My 2cents is that now that Trump is president, why not be in TSLA, BTDR, NAK, PEPE, BTC or anything else but this struggling company. Do you and hope PACB hits $100

Analyst Ratings

Scotiabank	Sector Outperform	Aug 28, 24
Stephens & Co.	Overweight	Aug 13, 24
Morgan Stanley	Equal-Weight	Aug 12, 24
Cantor Fitzgerald	Overweight	Aug 8, 24
Canaccord Genuity	Buy	Aug 8, 24
Jefferies	Buy	Jun 3, 24
Morgan Stanley	Equal-Weight	May 15, 24
Piper Sandler	Neutral	May 13, 24
Barclays	Equal-Weight	May 10, 24

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Van Oene Mark	See Remarks See Remarks	Jan 09	Sell	7.773	31,012	241,056	910,171	01/10/24
Kim Susan G.	See Remarks See Remarks	Sep 29	Sell	8.437	19,257	162,471	306,085	09/29/23
Eidel Jeff	See Remarks See Remarks	Aug 17	Sell	10.597	25,936	274,844	444,666	08/18/23
Farmer Michele	See Remarks See Remarks	May 18	Sell	12.59	5,165	65,027	107,577	05/19/23
Kim Susan G.	See Remarks See Remarks	Feb 17	Sell	10.271	907	9,316	162,581	02/22/23
HENRY CHRISTIAN O	See Remarks See Remarks	Feb 17	Sell	10.271	1,530	15,715	642,021	02/22/23
Van Oene Mark	See Remarks See Remarks	Jan 10	Sell	9.534	26,722	254,768	640,808	01/11/23
Kim Susan G.	See Remarks See Remarks	Sep 29	Sell	5.614	12,968	72,802	163,488	10/03/22
MOHR MARSHALL	Director Director	Jun 10	Option	1.83	35,000	64,050	60,000	06/13/22
Farmer Michele	See Remarks See Remarks	May 18	Sell	5.547	3,573	19,819	60,354	05/20/22
ORDONEZ KATHY	Director Director	Feb 16	Sell	11.5	3,280	37,720	18,595	02/17/22
MOHR MARSHALL	Director Director	Jan 14	Option	3.57	25,000	89,250	25,000	01/19/22
Van Oene Mark	Chief Operating Offi.. Chief Operating Officer	Jan 11	Sell	14.23	41,480	590,260	293,520	01/13/22
Fromen Peter	Chief Commercial Off.. Chief Commercial Officer	Jan 11	Sell	14.3	19,720	281,996	140,280	01/13/22
Ericson William W.	Director Director	May 26	Option	6.21	37,500	232,875	37,500	05/26/21
Hunkapiller Michael	Director Director	Feb 26	Option	6.27	605,804	3,798,391	1,187,782	02/26/21
Hunkapiller Michael	Director Director	Feb 26	Sell	34.83	605,804	21,100,153	848,405	02/26/21
ORDONEZ KATHY	Director Director	Feb 18	Option	5.18	185,879	962,853	242,646	02/18/21
ORDONEZ KATHY	Director Director	Feb 18	Sell	48.35	220,771	10,674,278	21,875	02/18/21
LIVINGSTON RANDALL S	Director Director	Feb 17	Option	4.98	67,500	336,150	67,500	02/17/21
LIVINGSTON RANDALL S	Director Director	Feb 17	Sell	48.07	67,500	3,244,725		02/17/21
Botstein David	Director Director	Feb 17	Option	4.58	160,000	732,800	160,000	02/17/21
Botstein David	Director Director	Feb 17	Sell	49.85	160,000	7,976,000		02/17/21
Hunkapiller Michael	Director Director	Jan 27	Option	6.14	125,406	769,993	973,811	01/27/21
Hunkapiller Michael	Director Director	Jan 27	Sell	36.53	125,406	4,581,081	848,405	01/27/21
Hunkapiller Michael	Director Director	Jan 22	Option	4.21	574,594	2,419,041	999,262	01/22/21
Hunkapiller Michael	Director Director	Jan 22	Sell	37.87	624,404	23,646,179	848,405	01/22/21
Hunkapiller Michael	Director Director	Dec 23	Option	4.72	700,000	3,304,000	1,262,666	12/23/20
Hunkapiller Michael	Director Director	Dec 23	Sell	23.88	700,000	16,716,000	898,215	12/23/20